Thomas DeLauer MOTS-c coverage explained: what the peptide is, how it works in research, dosing claims, and safety caveats for US buyers today.
Thomas DeLauer is a fitness and nutrition YouTuber who has discussed MOTS-c in videos about fasting, metabolic health, and compounds marketed as "exercise mimetics." MOTS-c is a mitochondrial-derived peptide that researchers study for its role in insulin sensitivity and cellular energy use. It is not FDA-approved for human use, and no prescription MOTS-c product is available in the United States.
Who Is Thomas DeLauer, and Why Do People Search His Name With MOTS-c?
Thomas DeLauer built a large YouTube following by covering keto diets, intermittent fasting, fat loss, and longevity research. His channel translates dense scientific papers into plain language, which is why viewers often look up a compound immediately after watching a breakdown.
Most people who type thomas delauer mots c into a search bar want two things: a simple explanation of what the peptide does, and a sense of whether the video overstated the evidence. Those are fair questions, because the gap between animal research and human reality is wide for nearly every peptide in this category.
DeLauer is not a physician, and his videos are educational content rather than medical advice. That distinction matters when the subject is a compound with no approved human use.
What MOTS-c Is, in Plain English
MOTS-c stands for "mitochondrial open reading frame of the 12S rRNA type-c." It is a short peptide — 16 amino acids — encoded inside mitochondrial DNA rather than nuclear DNA. Researchers first described it in 2015 as a mitochondrial signal that can travel to the nucleus and influence gene expression.
Because of that behavior, scientists sometimes describe MOTS-c as a mitochondrial hormone. The research themes that appear most often are:
- Insulin sensitivity. Rodent studies report improved glucose handling in diet-induced obesity models.
- AMPK activation. MOTS-c appears to switch on AMPK, the same energy-sensing pathway triggered by exercise and calorie restriction.
- Exercise capacity. Mice given MOTS-c have shown better physical performance in some experiments.
- Metabolic aging. Levels appear to decline with age in animal models, which has fueled longevity speculation.
The critical caveat is that nearly all of this work is in mice, worms, or cultured cells. MOTS-c has no published human trials with safety and dosing data.
What the Videos Get Right — and What They Leave Out
DeLauer's MOTS-c coverage generally tracks the animal literature accurately. He connects the peptide to fasting, exercise, and AMPK signaling, which is where the published research actually lives.
Where videos tend to fall short is the translation step. A mouse result is not a human protocol, and a plausible mechanism is not proof of benefit.
| Claim you may hear in a video | What the published research actually shows |
|---|---|
| MOTS-c improves insulin sensitivity | Shown in obese mice; no completed human trials |
| MOTS-c mimics exercise | Improved exercise capacity in rodents; no human performance data |
| MOTS-c is a longevity peptide | Speculative; no human lifespan or healthspan outcomes |
| MOTS-c is safe to inject | No published human safety, dosing, or toxicity data |
None of this makes MOTS-c worthless as a research target. It means the human story is unwritten, and a YouTube summary cannot substitute for clinical evidence.
How MOTS-c Compares to Other Metabolic Peptides
Anyone researching aod 9604 vs mots-c is usually comparing two very different molecules that get lumped into the same fat-loss bucket. The same confusion shows up in searches for aod 9604 mots c tesamorelin ipamorelin — four compounds with four distinct mechanisms and regulatory statuses.
| Peptide | What it is | Main research focus | FDA status |
|---|---|---|---|
| MOTS-c | Mitochondrial-derived peptide (16 amino acids) | Insulin sensitivity, AMPK, energy metabolism | Not approved for human use |
| AOD-9604 | Synthetic fragment of human growth hormone (hGH 176-191) | Fat metabolism; human trials show mixed results | Not approved; FDA has warned about supplement marketing |
| Tesamorelin | Growth hormone-releasing hormone analog | Visceral fat reduction in HIV-associated lipodystrophy | FDA-approved as Egrifta, prescription only |
| Ipamorelin | Selective growth hormone secretagogue | Growth hormone release in early-stage trials | Not approved for human use |
Tesamorelin is the only one of the four with an FDA approval, and that approval is narrow: it is prescribed for a specific diagnosis under a physician's supervision.
Can You Stack MOTS-c With AOD-9604 or Tesamorelin?
There is no clinical research on aod-9604 and mots-c together, and no published human data on combining a mitochondrial peptide with a growth hormone secretagogue. Online protocols exist, but they are user-generated rather than evidence-based.
Stacking also multiplies risk. Each compound carries its own unknowns, and overlapping effects on blood sugar, insulin, and growth hormone signaling are difficult to predict in a living person. Combining unregulated injectables adds infection risk from non-sterile product and dosing errors from mislabeled vials.
Research-use-only peptides are not tested for sterility, purity, or identity the way pharmaceutical products are. The label "not for human consumption" is a legal disclaimer, not marketing copy.
Dosage Claims, Safety, and Legal Reality in the US
Search interest in aod 9604 mots-c tesamorelin dosage usually reflects the same problem: people want a number, and the honest answer is that no validated number exists for MOTS-c or AOD-9604. Tesamorelin is the exception, and its dose is set by a prescriber for an approved diagnosis rather than chosen from a forum.
For unapproved peptides, any dosing information you find online comes from self-experimenters, vendor marketing, or extrapolation from mouse studies. None of those sources can establish safety.
What US Buyers Should Know Before Ordering
- MOTS-c is not FDA-approved for any human indication, and no pharmacy dispenses it by prescription.
- Peptides sold as research chemicals are not quality-controlled for human injection.
- Reported problems with unregulated peptide use include injection site reactions, blood sugar changes, and hormone-related side effects.
- Importing or possessing unapproved injectable peptides can create legal exposure depending on state and circumstance.
If your goal is better insulin sensitivity or body composition, interventions with real human data — resistance training, sleep, adequate protein, and clinician-supervised medications — carry far more evidence than any research peptide.
Bottom Line on Thomas DeLauer and MOTS-c
Thomas DeLauer's MOTS-c content is a useful introduction to the research, but it summarizes animal studies rather than establishing a human protocol. MOTS-c is not FDA-approved for human use in the United States. AOD-9604 and ipamorelin also lack approved human use and established dosing, while tesamorelin is prescription-only for a narrow indication. Anyone considering these compounds should talk with a licensed healthcare professional first.
Frequently Asked Questions
Did Thomas DeLauer recommend MOTS-c?
Thomas DeLauer has discussed MOTS-c in videos about metabolism, fasting, and exercise signaling, generally summarizing published research rather than issuing a formal recommendation. He is not a physician, and his channel is educational content. Anyone considering peptides should speak with a licensed healthcare professional.
Is MOTS-c FDA-approved for human use?
No. MOTS-c is not FDA-approved for any human indication, and no prescription MOTS-c product exists in the United States. It is sold online as a research chemical labeled "not for human consumption," which means purity, sterility, and dosing are unverified.
What is the difference between MOTS-c and AOD-9604?
AOD-9604 is a synthetic fragment of human growth hormone studied for fat metabolism, while MOTS-c is a mitochondrial-derived peptide studied for insulin sensitivity and cellular energy use. Neither is FDA-approved for human use. Tesamorelin, by contrast, is FDA-approved by prescription for a narrow diagnosis involving visceral fat.
This page provides educational research information and does not replace medical advice, diagnosis, or treatment.